Disc Medicine (IRON) Operating Expenses (2020 - 2026)
Disc Medicine's (IRON) quarterly Operating Expenses came in at $69.5 million in Q1 2026, up 74.04% year-on-year from $39.9 million in Q1 2025, and up 3.81% on a QoQ basis from $67.0 million in Q4 2025.
Disc Medicine (IRON) Operating Expenses (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Operating Expenses data on file, last reported at $69.5 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 74.04% year-over-year to $69.5 million in Q1 2026; TTM through Mar 2026 was $265.6 million, a 92.18% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, up 81.95% from the prior year.
- Operating Expenses for Q1 2026 stood at $69.5 million, up from $67.0 million in the prior quarter.
- Over the last five years, Operating Expenses for IRON reached as high as $69.5 million in Q1 2026 and fell as low as $10.0 million in Q1 2022.
- Historically, Operating Expenses has averaged $33.8 million across 5 years, with a median of $30.9 million in 2024.
- On a YoY basis, Operating Expenses climbed as much as 173.9% in 2022 and fell as far as 43.2% in 2022.
- Year by year, Operating Expenses stood at $15.0 million in 2022, then jumped by 97.82% to $29.7 million in 2023, then gained by 16.28% to $34.6 million in 2024, then soared by 93.84% to $67.0 million in 2025, then grew by 3.81% to $69.5 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $69.5 million in Q1 2026, $67.0 million in Q4 2025, and $67.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Disc Medicine | 2.86 Bn | 2.86 Bn | - | 69.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.52 Mn |
| Dec 31, 2025 | 66.97 Mn |
| Sep 30, 2025 | 67.70 Mn |
| Jun 30, 2025 | 61.41 Mn |
| Mar 31, 2025 | 39.95 Mn |
| Dec 31, 2024 | 34.55 Mn |
| Sep 30, 2024 | 32.86 Mn |
| Jun 30, 2024 | 30.85 Mn |
| Mar 31, 2024 | 31.46 Mn |
| Dec 31, 2023 | 29.71 Mn |
| Sep 30, 2023 | 18.96 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 25.13 Mn |
| Dec 31, 2022 | 15.02 Mn |
| Sep 30, 2022 | 10.48 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 9.96 Mn |
| Dec 31, 2021 | -20.33 Mn |
| Sep 30, 2021 | 18.45 Mn |
| Jun 30, 2021 | 16.32 Mn |